AVP Receptor V2 Activators

AVP Receptor V2 (AVPR2) Activators are a diverse set of compounds that can directly or indirectly stimulate the activity of AVPR2, a key receptor in water homeostasis. The most direct activators of AVPR2 are naturally occurring or synthetic analogues of arginine vasopressin, such as AVP itself or DDAVP. These compounds bind directly to AVPR2 and activate the receptor, triggering a series of intracellular events that include the activation of adenylate cyclase, an increase in cAMP levels, and the activation of protein kinase A (PKA). This series of events is central to the downstream processes mediated by AVPR2, such as water reabsorption in the kidney. A unique group of AVPR2 activators are non-peptide AVPR2 antagonists that can act as agonists under certain conditions. Compounds in this group, such as OPC-31260, OPC-41061, Lixivaptan, Mozavaptan, Satavaptan, Conivaptan, Tolvaptan, SR121463, YM087, bind to AVPR2 and activate the receptor, leading to increased cAMP levels and PKA activation, just like the vasopressin analogues. These compounds are unique in their ability to bind and activate AVPR2, despite their initial characterization as antagonists. Furthermore, there are compounds like Rolofylline, an adenosineA1 receptor antagonist, that indirectly influence AVPR2 activity. By increasing cAMP levels, Rolofylline can indirectly stimulate AVPR2, highlighting the complex interplay of different signaling pathways involved in modulating AVPR2 activity.